vimarsana.com
Home
Live Updates
SJS/TEN: Study Addresses Issues in Identifying Culprit Drug
SJS/TEN: Study Addresses Issues in Identifying Culprit Drug
SJS/TEN: Study Addresses Issues in Identifying Culprit Drug
In the absence of a lab test, identifying culprit drugs in patients with SJS/TEN is difficult, and 'patients take on average six medications at the time of their reaction,' the authors of a new study write.
Related Keywords
Washington ,
United States ,
Boston ,
Massachusetts ,
George Washington University Hospital ,
District Of Columbia ,
Christine Ko ,
Karl Saardi ,
Sherriej Divito ,
Yale University ,
Drug Causality ,
Epidermal Necrolysis ,
Massachusetts General Hospital ,
New Haven ,
Skin And Soft Tissue Infection ,
Stevens Johnson Syndrome ,
Hospitals ,
Patient Safety ,
Allergy ,
Fixed Drug Eruption ,
Human Leukocyte Antigen ,
La Human Leukocyte Antigen ,
Allergens ,
Antigens ,
Drug Induced Cutaneous Eruptions ,
Inpatient Care ,
Medical Records ,
Records ,
Antibiotics ,
Igecycline ,
Social Determinants Of Health ,